(NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, ... Dr. Megerian's presentation will focus on these previously reported data. ... EPIX expects to initiate these trials in the first half of 2008,
|
www.medicalnewstoday.com/articles/101922.php
|
|
(Amex: ANX), announced that data from preclinical studies of ANX-201, the Company's broad spectrum antiviral product candidate, has been accepted for presentation at the ... The HIV Pathogenesis Conference is part of the Keystone Symposia Global Health Series, which is supported by the Bill & Melinda Gates Foundation.
|
www.medicalnewstoday.com/articles/95807.php
|
|
|
Mirna Therapeutics presents data at Keystone Symposium on MicroRNA and; Cancer; Systemic delivery of a mimic for miR-34 as a microRNA replacement therapy inhibits tumor growth and metastasis in multiple animal models of cancer;
|
www.mirnatherapeutics.com/pdfs/Mirna%20061509%20keyston...
www.mirnatherapeutics.com/pdfs/Mirna%20061509%20keystone%20symposia.pdf
|
|
|
|
PLYMOUTH MEETING, Pa., January 22, 2009 /PRNewswire-FirstCall/Genaera Corporation today announced a poster presentation of preclinical data on trodusquemine (MSI-1436), Genaera's lead drug candidate for the treatment of type 2 diabetes and obesity, during the Keystone Symposia: Obesity - Novel Aspects of the Regulation...
|
www.drugs.com/clinical_trials/genaera-presents-promisin...
www.drugs.com/clinical_trials/genaera-presents-promising-preclinical-data-trodusquemine-msi-1436-keystone-symposia-6638.html
|
|
|
Keystone Symposia Meeting, Part 2—Genetics and Epidemiology of AD ... RELATED NEWS; Keystone Symposia Meeting, Part 1—Alzheimer’s Disease: Genes, Cellular Pathways and Therapies; Keystone Symposia Meeting, Part 3—Amyloid Precursor Protein Function; Keystone Symposia Meeting, Part 4—Presenilin and γ-secretase;
|
www.alzforum.org/new/detail.asp?id=1371
|
|
Keystone Symposia is pleased to announce that it has received a second grant from the Bill & Melinda Gates Foundation worth $2.7 million over three years to fund meetings and Global Health Travel Awards in the Keystone Symposia Global Health Series. ... Keystone Symposia aims to make its conferences open,
|
www.eurekalert.org/pub_releases/2009-11/ksom-ksa110509....
www.eurekalert.org/pub_releases/2009-11/ksom-ksa110509.php
|
|
Organized in 1972 as the UCLA Symposia on Molecular and Cellular Biology, the organization later became a subsidiary of The Keystone Center and was renamed Keystone Symposia. In 1997, Keystone Symposia became an independent 501(c)(3) nonprofit organization based in Silverthorne, Colorado.
|
www.facebook.com/KeystoneSymposia
www.facebook.com/KeystoneSymposia
|
|
SILVERTHORNE — Tucked away in a suite of offices above a thrift shop in Silverthorne, Keystone Symposia employs about 30 local people, has an (read more) ... Attendees at a Keystone Symposia conference on TB and AIDS in Tanzania last month. While the organization does most of its conferences in North America, it is trying...
|
www.summitdaily.com/article/20091110/NEWS/911109997/107...
www.summitdaily.com/article/20091110/NEWS/911109997/1078&ParentProfile=1055
|
|
Organizer Keystone Symposia on Molecular and Cellular Biology ... Keystone Symposia: Hypoxia: Molecular Mechanisms of Oxygen Sensing and Response Pathways ... Keystone Symposia: New Insights into Healthspan and Diseases of Aging: From Molecular to Functional Senescence...
|
www.cell.com/conferences/viewDetail/Keystone%20Symposia...
www.cell.com/conferences/viewDetail/Keystone%20Symposia:%20Stem%20Cell%20Differentiation%20and%20Dedifferentiation
|
|
